Treatment of Lung Cancer by Carbon Nanotubes

Abstract

Due to its elevated prevalence, the significance of early detection and the full management of lung cancer to most patients with this dangerous illness rises every day. Since they have fair damage, diagnosis and therapy are useful in assisting the nanoparticles. This report lays out that the negative effects of carbon nanotube (CNT) use, like swelling, fibrosis, and carcinogenesis, are very troublesome in this disease treatment process. Utilizing strategies like functionalizing to the right dimensions as a longer length, greater width, with greater curvature, toxicity can decrease to a certain degree.  Different modified vapours can be linked to the specific CNT sensors. In this respect, imaging enables non-invasive detection achievable with the aid of this process. Studies have also suggested that nanomaterials like CNTs may be used, particularly with chemotherapeutic agents, as carriers for direct drug delivery. For cancer cells targeting, most of these carrier were multi-wall carbon nanotubes (MWCNT) utilized. In the area of diagnosis and treatment, the findings of lab and testing on animals have been very beneficial and optimistic. The reviewed series of research highlighted the need for a thorough evaluation involving the CNT dosage, length, induction process, etc., in order to obtain the most controlled situations for human and animal studies. Four conflicting topics are addressed in the discussion section, which encourages investigators to do further studies to get clear results.